FR2317915A1 - Analogues de prostaglandines et leur preparation - Google Patents

Analogues de prostaglandines et leur preparation

Info

Publication number
FR2317915A1
FR2317915A1 FR7621528A FR7621528A FR2317915A1 FR 2317915 A1 FR2317915 A1 FR 2317915A1 FR 7621528 A FR7621528 A FR 7621528A FR 7621528 A FR7621528 A FR 7621528A FR 2317915 A1 FR2317915 A1 FR 2317915A1
Authority
FR
France
Prior art keywords
preparation
prostaglandin analogues
prostaglandin
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7621528A
Other languages
English (en)
Other versions
FR2317915B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2317915A1 publication Critical patent/FR2317915A1/fr
Application granted granted Critical
Publication of FR2317915B1 publication Critical patent/FR2317915B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/72—Acyl halides containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7621528A 1975-07-14 1976-07-13 Analogues de prostaglandines et leur preparation Granted FR2317915A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/595,869 US4026909A (en) 1975-07-14 1975-07-14 Cis-13-PGF2.sub.α analogs

Publications (2)

Publication Number Publication Date
FR2317915A1 true FR2317915A1 (fr) 1977-02-11
FR2317915B1 FR2317915B1 (fr) 1982-10-22

Family

ID=24385022

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7621528A Granted FR2317915A1 (fr) 1975-07-14 1976-07-13 Analogues de prostaglandines et leur preparation

Country Status (14)

Country Link
US (24) US4026909A (fr)
JP (1) JPS5210243A (fr)
AU (1) AU500639B2 (fr)
BE (1) BE844105A (fr)
CA (1) CA1064483A (fr)
CH (1) CH625797A5 (fr)
DE (1) DE2630879A1 (fr)
FR (1) FR2317915A1 (fr)
GB (1) GB1554022A (fr)
HU (1) HU177771B (fr)
MX (1) MX3343E (fr)
NL (1) NL7607728A (fr)
SE (1) SE432593B (fr)
ZA (1) ZA763765B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0857718A1 (fr) * 1996-06-10 1998-08-12 R-Tech Ueno, Ltd. Antagoniste de l'endotheline

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190587A (en) * 1973-08-06 1980-02-26 Hoffmann-La Roche Inc. 4-(3-Oxo-4-trifluoromethyl-1-octenyl)-2-oxo-2H-cyclopenta[b]furans
US4237276A (en) * 1974-06-18 1980-12-02 Hoffmann-La Roche Inc. Bicyclic lactone intermediates for 16-substituted prostaglandins
US4183870A (en) * 1974-01-26 1980-01-15 May & Baker Limited Cyclopentane derivatives
US4123456A (en) * 1974-11-07 1978-10-31 American Cyanamid Company Novel 11-hydroxy-9-keto-5,6-cis-13,14-cis-prostadienoic acid derivatives
US4016184A (en) * 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4207227A (en) * 1976-12-03 1980-06-10 Bayer Aktiengesellschaft Stable suspensions of inorganic fillers in organic polyhydroxyl compounds
DE2739620A1 (de) * 1977-09-02 1979-03-08 Bayer Ag Stabile suspensionen anorganischer fuellstoffe in organischen polyhydroxylverbindungen
US4312810A (en) * 1978-11-22 1982-01-26 The Upjohn Company 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-9-deoxy-PGF1 compounds
JPH0382248U (fr) * 1989-12-12 1991-08-22
US5262437A (en) * 1990-12-10 1993-11-16 Allergan, Inc. Homo-prostaglandin derivatives as ocular hypotensives
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
WO2003099272A1 (fr) 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Inhibiteurs d'histone desacetylase bases sur des composes alpha-ceto-epoxydes
JP2006508986A (ja) 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
US8487147B2 (en) * 2010-03-01 2013-07-16 Syed Tajammul Hussain Nano-catalyst for fast track bio-diesel production from non-edible oils

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959346A (en) * 1969-03-14 1976-05-25 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
JPS503362B1 (fr) * 1970-06-10 1975-02-04
DE2317019A1 (de) * 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
US3816383A (en) * 1972-05-01 1974-06-11 Nat Petro Chem Separation of olefin polymers
US4011262A (en) * 1972-07-13 1977-03-08 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
US3867377A (en) * 1972-07-18 1975-02-18 Syntex Inc Method of making 13-cis prostaglandin derivatives
US4046801A (en) * 1972-07-18 1977-09-06 Syntex (U.S.A.) Inc. 13-Cis prostaglandin derivatives
US3873607A (en) * 1972-07-24 1975-03-25 American Cyanamid Co 3-Oxa(and thia) 11-deoxy PGE
US3933899A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGE2 -oxa-phenylene compounds
US3914282A (en) * 1973-01-16 1975-10-21 Upjohn Co Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs
US3932479A (en) * 1973-04-27 1976-01-13 American Cyanamid Company Lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
US3962293A (en) * 1973-07-20 1976-06-08 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin F1
US3932463A (en) * 1974-06-03 1976-01-13 American Cyanamid Company 11-Deoxy-13-dihydro-prostaglandin-9-ketals
US3970685A (en) * 1974-06-05 1976-07-20 Syntex (U.S.A.) Inc. (DL)-13-Substituted sulfinyl-prostaglandin-like compounds

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0857718A1 (fr) * 1996-06-10 1998-08-12 R-Tech Ueno, Ltd. Antagoniste de l'endotheline
EP0857718A4 (fr) * 1996-06-10 1999-07-28 R Tech Ueno Ltd Antagoniste de l'endotheline
US6242485B1 (en) 1996-06-10 2001-06-05 R-Tech Ueno Endothelin antagonist
US6452039B1 (en) * 1996-06-10 2002-09-17 Ryuji Ueno Endothelin antagonist
CN100337632C (zh) * 1996-06-10 2007-09-19 苏坎波公司 内皮素拮抗剂

Also Published As

Publication number Publication date
US4118581A (en) 1978-10-03
US4122103A (en) 1978-10-24
AU1528176A (en) 1978-01-05
US4163107A (en) 1979-07-31
US4122284A (en) 1978-10-24
US4161606A (en) 1979-07-17
US4088663A (en) 1978-05-09
SE7607875L (sv) 1977-01-15
US4118580A (en) 1978-10-03
US4026909A (en) 1977-05-31
US4129582A (en) 1978-12-12
US4122100A (en) 1978-10-24
US4127723A (en) 1978-11-28
AU500639B2 (en) 1979-05-31
HU177771B (en) 1981-12-28
US4127726A (en) 1978-11-28
GB1554022A (en) 1979-10-17
US4122283A (en) 1978-10-24
US4118578A (en) 1978-10-03
NL7607728A (nl) 1977-01-18
US4122101A (en) 1978-10-24
US4122102A (en) 1978-10-24
US4085271A (en) 1978-04-18
JPS5210243A (en) 1977-01-26
US4119651A (en) 1978-10-10
US4161605A (en) 1979-07-17
BE844105A (fr) 1977-01-14
US4119787A (en) 1978-10-10
ZA763765B (en) 1977-05-25
DE2630879A1 (de) 1977-02-03
CH625797A5 (fr) 1981-10-15
US4127725A (en) 1978-11-28
SE432593B (sv) 1984-04-09
MX3343E (es) 1980-10-01
US4120878A (en) 1978-10-17
US4127724A (en) 1978-11-28
US4118579A (en) 1978-10-03
FR2317915B1 (fr) 1982-10-22
CA1064483A (fr) 1979-10-16

Similar Documents

Publication Publication Date Title
FR2317915A1 (fr) Analogues de prostaglandines et leur preparation
BE846340A (fr) Analogues de prostaglandines et leur preparation
BE815354A (fr) Prostaglandines et leur preparation
BE857761A (fr) Analogues de prostaglandines et leur preparation
BE838582A (fr) Nouveaux analogues de prostaglandines et procedes pour leur preparation
BE849963A (fr) Analogues de prostaglandines et leur preparation
BE862547A (fr) Analogues de protaglandines et leur preparation
FR2326185A1 (fr) Nouveaux analogues des prostaglandines et leur preparation
BE856099A (fr) Nouveaux analogues de prostaglandines et leur preparation
BE854271A (fr) Analogues de prostaglandines et leur preparation
BE841770A (fr) Preparation de 2-aryl-2h-benzotriazoles
FR2317916A1 (fr) Analogues de prostaglandines et leurs procedes de preparation
BE837865A (fr) Analogues de prostaglandines et leur preparation
BE855224A (fr) Analogues de 5,6-dihydro-prostacycline et leur preparation
FR2301241A1 (fr) Nouveaux derives de prostaglandines et leur preparation
BE853801A (fr) Analogues de prostaglandines et leur preparation
FR2299022A1 (fr) Antagonistes de prostaglandines
FR2328701A1 (fr) Preparation de 2-amino-1-alcools
FR2308357A1 (fr) Nouveaux analogues de prostaglandines et leur preparation
BE846080A (fr) Analogues de prostaglandines et leur preparation
BE857161A (fr) Nouveaux analogues de prostaglandines et leur preparation
BE834133A (fr) Nouvelles prostaglandines substituees et leur preparation
FR2320084A1 (fr) Analogues de prostaglandines
BE804873A (fr) Derives analogues de prostaglandines et leur preparation
BE842275A (fr) Prostaglandines, leur preparation et leur utilisation

Legal Events

Date Code Title Description
ST Notification of lapse